Riskpilot← Back to searchSign inGet full accessA Bioscience Incentive AB
ABActiveOrg 5590563663223 81 LundEconomic activity was not specified by tax authority · NACE 0000Est. 20160 employees
Revenue 2024
SEK 0
EBITDA margin
—
0% vs 2023
Equity ratio
11.5%
Financial strength
Net profit 2024
SEK 0
0 employees
| Revenue | SEK 0 | — |
| EBITDA | SEK -5K | +0% |
| Net profit | SEK 0 | — |
| Total assets | SEK 1,4M | +49% |
| Equity | SEK 157K | +0% |
| Employees | 0 | — |
Legal name
A Bioscience Incentive AB
Org number
5590563663
Legal form
Aktiebolag
NACE code
0000 · Economic activity was not specified by tax authority
Founded
24 mars 2016
Share capital
SEK 50 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas i förening av ledamöterna
Company purpose
Bolaget ska teckna, förvärva och överlåta optioner och andra värdepapper utställda av bolag inom den koncern som bolaget från tid till annan tillhör samt bedriva annan därmed förenlig verksamhet.
Address
223 81 Lund
Email
info@alligatorbioscience.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Staff expenses | — | — | — | — | — | — | — | — | — |
| EBITDA | — | −1 | −1 | −1 | −2 | −4 | −6 | −5 | −5 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 |
| EBIT | 0 | −1 | −1 | −1 | −2 | −4 | −6 | −5 | −5 |
| Net financials | −4 | — | — | −246 | — | — | 413 | 359 | 451 |
| Profit before tax | −4 | −1 | −1 | −124 | −2 | −4 | 0 | 0 | 0 |
| Tax | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 |
| Net profit | −4 | −1 | −1 | −124 | −2 | −4 | 0 | 0 | 0 |
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|
| Total assets | 289 | 288 | 287 | 163 | 161 | 157 | 564 | 917 | 1 363 |
| Equity | 289 | 288 | 287 | 163 | 161 | 157 | 157 | 157 | 157 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 407 | 761 | 1 206 |
| Total debt | — | — | — | — | — | — | 407 | 761 | 1 206 |
EBITDA margin
-500000.0%
This company
15.8%
Market median
-3164657% vs market
20162024
Equity ratio
11.5%
This company
38.2%
Market median
-70% vs market
20162024
Return on equity
0.0%
This company
18.4%
Market median
-100% vs market
20162024
Net profit margin
0.0%
This company
8.1%
Market median
-100% vs market
20162024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20162024
Debt / equity
7.68×
This company
0.62×
Market median
-1139% vs market
20162024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Bolagsverket / SCB · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Bolagsverket / SCB · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Bolagsverket / SCB · Period 2016-03-01 – 2016-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
TJ Chief Auditor | Chief Auditor | 2020 | — | — |
OC Chief Auditor | Chief Auditor | 2022 | — | — |
AO Chief Auditor | Chief Auditor | 2022 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2021 | — | — | |
| Deputy Board Member | 2022 | — | — | |
| Deputy Board Member | 2025 | — | — | |
| Board of Directors | 2020 | — | — | |
| Chairman | 2021 | — | — | |
| Chairman | 2022 | — | — | |
| Board of Directors | 2025 | — | — | |
| Chairman | 2020 | — | — | |
| Deputy Board Member | 2020 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Alligator Bioscience AB | Company | 100.0% | 100.0% | 0001 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Alligator Bioscience AB
A Bioscience Incentive AB Board members of A Bioscience Incentive AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Tomas Johan Thuresson | Chief Auditor | 0 companies |
| Ola Christopher Carelius Larsmon | Chief Auditor | 0 companies |
| Anders Ola Bjärehäll | Chief Auditor | 0 companies |
| Eva Marie Gabrielle Svensson | Board of Directors | 0 companies |
| Laura Ila von Schantz | Deputy Board Member | 0 companies |
| Greta Katarina Höög | Deputy Board Member | 0 companies |
| Per-Olof Palle Schrewelius | Board of Directors | 0 companies |
| Tora Malin Elisabeth Carlsson | Chairman | 0 companies |
| Søren Bregenholt Frederiksen | Chairman | 0 companies |
| Carl Johan Giléus | Board of Directors | 0 companies |
| Per Göran Oskar Norlén | Chairman | 0 companies |
| Tina Anna Furebring | Deputy Board Member | 0 companies |